Showing results (281-290 of 2,493) with videos related to
Sort By:
Pageof 250
The Journal of Infectious Diseases|August 1, 1993
Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placementI Raad, W Costerton, U Sabharwal, et al.Cancer|May 15, 1981
Protected environment - prophylactic antibiotic program for malignant sarcomas: randomized trial during remission induction chemotherapyG P Bodey, V Rodriguez, W K Murphy, et al.Journal of Clinical Microbiology|July 1, 1982
Diagnostic value of the enzyme-linked immunosorbent assay for detection of Candida albicans cytoplasmic antigen in sera of cancer patientsG F Araj, R L Hopfer, S Chesnut, et al.The Journal of Antimicrobial Chemotherapy|October 1, 1987
In-vitro activity of LY146032 against gram-positive isolates from cancer patientsH Saito, K V Rolston, D H Ho, et al.The Journal of Antimicrobial Chemotherapy|May 1, 1990
The activity in vitro of trospectomycin sulphate (U-63366F) against aminoglycoside-resistant enterococciN Khardori, M Gandhi, J Adame, et al.Chest|October 1, 1988
Bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in patients with acute leukemiaH Saito, E J Anaissie, R C Morice, et al.American Journal of Clinical Oncology|August 1, 1983
Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with upper gastrointestinal tumors. A preliminary reportA Y Bedikian, J Stroehlein, J Korinek, et al.American Journal of Clinical Oncology|June 1, 1982
Phase II trail of PCNU in refractory advanced breast cancerJ J Kavanagh, H Y Yap, G R Blumenschein, et al.Southern Medical Journal|August 1, 1981
Colorectal cancer in young adultsA Y Bedikian, H Kantarjian, R S Nelson, et al.American Journal of Clinical Oncology|February 1, 1983
Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with metastatic colorectal cancerA Y Bedikian, J Stroehlein, J Korinek, et al.Pageof 250